Epicardial placement of mesenchymal stromal cell-sheets for the treatment of ischemic cardiomyopathy; In vivo proof-of-concept study

Molecular Therapy

Volumn 22, Issue 10, 2014, Pages 1864-1871

  Tano, Nobuko ^a   Narita, Takuya ^a   Kaneko, Masahiro ^a   Ikebe, Chiho ^a   Coppen, Steven R ^a   Campbell, Niall G ^a   Shiraishi, Manabu ^a   Shintani, Yasunori ^a   Suzuki, Ken ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; HYPOXIA INDUCIBLE FACTOR 1ALPHA; SOMATOMEDIN C; STROMAL CELL DERIVED FACTOR 1ALPHA; TISSUE INHIBITOR OF METALLOPROTEINASE 1; VASCULAR CELL ADHESION MOLECULE 1;

ACUTE HEART INFARCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARY DENSITY; CELL DIFFERENTIATION; CELL SURVIVAL; CELL TRANSPLANTATION; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE SIZE; IN VIVO STUDY; ISCHEMIC CARDIOMYOPATHY; MACROPHAGE; MESENCHYMAL STROMA CELL; MESENCHYMAL STROMA CELL SHEET THERAPY; NONHUMAN; PARACRINE SIGNALING; RAT; TISSUE REPAIR; UPREGULATION; ANIMAL; CYTOLOGY; DISEASE MODEL; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MYOCARDIAL ISCHEMIA; PATHOPHYSIOLOGY; PERICARDIUM; REGENERATION; TISSUE REGENERATION; TISSUE SCAFFOLD;

RATTUS;

ANIMALS; CELL DIFFERENTIATION; CELL SURVIVAL; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; FEMALE; GUIDED TISSUE REGENERATION; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MYOCARDIAL ISCHEMIA; PERICARDIUM; RATS; REGENERATION; TISSUE SCAFFOLDS;

EID: 84926135977     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2014.110     Document Type: Article

References (33)

1. Kode, JA, Mukherjee, S, Joglekar, MV and Hardikar, AA (2009). Mesenchymal stem cells: immunobiology and role in immunomodulation and tissue regeneration. Cytotherapy 11: 377-391.
2. Lazarus, HM, Haynesworth, SE, Gerson, SL, Rosenthal, NS and Caplan, AI (1995). Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): implications for therapeutic use. Bone Marrow Transplant 16: 557-564.
3. Sanganalmath, SK and Bolli, R (2013). Cell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directions. Circ Res 113: 810-834.
4. Malliaras, K, Li, TS, Luthringer, D, Terrovitis, J, Cheng, K, Chakravarty, T et al. (2012). Safety and efficacy of allogeneic cell therapy in infarcted rats transplanted with mismatched cardiosphere-derived cells. Circulation 125: 100-112.
5. Williams, AR and Hare, JM (2011). Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease. Circ Res 109: 923-940.
6. Campbell, NG and Suzuki, K (2012). Cell delivery routes for stem cell therapy to the heart: current and future approaches. J Cardiovasc Transl Res 5: 713-726.
7. Fukushima, S, Sawa, Y and Suzuki, K (2013). Choice of cell-delivery route for successful cell transplantation therapy for the heart. Future Cardiol 9: 215-227.
8. Siltanen, A, Kitabayashi, K, Lakkisto, P, Mäkelä, J, Pätilä, T, Ono, M et al. (2011). hHGF overexpression in myoblast sheets enhances their angiogenic potential in rat chronic heart failure. PLoS One 6: e19161.
9. Narita, T, Shintani, Y, Ikebe, C, Kaneko, M, Campbell, NG, Coppen, SR et al. (2013). The use of scaffold-free cell sheet technique to refine mesenchymal stromal cell-based therapy for heart failure. Mol Ther 21: 860-867.
10. Kawamura, M, Miyagawa, S, Fukushima, S, Saito, A, Miki, K, Ito, E et al. (2013). Enhanced survival of transplanted human induced pluripotent stem cell-derived cardiomyocytes by the combination of cell sheets with the pedicled omental flap technique in a porcine heart. Circulation 128(11 suppl. 1): S87-S94.
11. Hamdi, H, Planat-Benard, V, Bel, A, Puymirat, E, Geha, R, Pidial, L et al. (2011). Epicardial adipose stem cell sheets results in greater post-infarction survival than intramyocardial injections. Cardiovasc Res 91: 483-491.
12. Gajarsa, JJ and Kloner, RA (2011). Left ventricular remodeling in the post-infarction heart: a review of cellular, molecular mechanisms, and therapeutic modalities. Heart Fail Rev 16: 13-21.
13. Breitbach, M, Bostani, T, Roell, W, Xia, Y, Dewald, O, Nygren, JM et al. (2007). Potential risks of bone marrow cell transplantation into infarcted hearts. Blood 110: 1362-1369.
14. Kaneko, M, Shintani, Y, Narita, T, Ikebe, C, Tano, N, Yamahara, K et al. (2013). Extracellular high mobility group box 1 plays a role in the effect of bone marrow mononuclear cell transplantation for heart failure. PLoS One 8: e76908.
15. Ben-Mordechai, T, Holbova, R, Landa-Rouben, N, Harel-Adar, T, Feinberg, MS, Abd Elrahman, I et al. (2013). Macrophage subpopulations are essential for infarct repair with and without stem cell therapy. J Am Coll Cardiol 62: 1890-1901.
16. Fukushima, S, Varela-Carver, A, Coppen, SR, Yamahara, K, Felkin, LE, Lee, J et al. (2007). Direct intramyocardial but not intracoronary injection of bone marrow cells induces ventricular arrhythmias in a rat chronic ischemic heart failure model. Circulation 115: 2254-2261.
17. Velazquez, EJ, Lee, KL, Deja, MA, Jain, A, Sopko, G, Marchenko, A et al.; STICH Investigators. (2011). Coronary-Artery bypass surgery in patients with left ventricular dysfunction. N Engl J Med 364: 1607-1616.
18. Donndorf, P, Kundt, G, Kaminski, A, Yerebakan, C, Liebold, A, Steinhoff, G et al. (2011). Intramyocardial bone marrow stem cell transplantation during coronary artery bypass surgery: a meta-Analysis. J Thorac Cardiovasc Surg 142: 911-920.
19. Kinsman, R and Systems, DC (2008). The Society for Cardiothoracic Surgery in Great Britain, & Ireland Sixth National Adult Cardiac Surgical Database Report. http://www. scts.org/-userfiles/resources/SixthNACSDreport2008withcovers.pdf.
20. Kimura, T, Miyoshi, S, Okamoto, K, Fukumoto, K, Tanimoto, K, Soejima, K et al. (2012). The effectiveness of rigid pericardial endoscopy for minimally invasive minor surgeries: cell transplantation, epicardial pacemaker lead implantation, and epicardial ablation. J Cardiothorac Surg 7: 117.
21. Richardson, JD, Bertaso, AG, Psaltis, PJ, Frost, L, Carbone, A, Paton, S et al. (2013). Impact of timing and dose of mesenchymal stromal cell therapy in a preclinical model of acute myocardial infarction. J Card Fail 19: 342-353.
22. Tian, H, Huang, ML, Liu, KY, Jia, ZB, Sun, L, Jiang, SL et al. (2012). Inhibiting matrix metalloproteinase by cell-based timp-3 gene transfer effectively treats acute and chronic ischemic cardiomyopathy. Cell Transplant 21: 1039-1053.
23. Sasagawa, T, Shimizu, T, Sekiya, S, Haraguchi, Y, Yamato, M, Sawa, Y et al. (2010). Design of prevascularized three-dimensional cell-dense tissues using a cell sheet stacking manipulation technology. Biomaterials 31: 1646-1654.
24. Gnecchi, M, Zhang, Z, Ni, A and Dzau, VJ (2008). Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res 103: 1204-1219.
25. Kinnaird, T, Stabile, E, Burnett, MS, Shou, M, Lee, CW, Barr, S et al. (2004). Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation 109: 1543-1549.
26. Kupcova Skalnikova, H (2013). Proteomic techniques for characterisation of mesenchymal stem cell secretome. Biochimie 95: 2196-2211.
27. Ranganath, SH, Levy, O, Inamdar, MS and Karp, JM (2012). Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease. Cell Stem Cell 10: 244-258.
28. Pinto, AR, Paolicelli, R, Salimova, E, Gospocic, J, Slonimsky, E, Bilbao-Cortes, D et al. (2012). An abundant tissue macrophage population in the adult murine heart with a distinct alternatively-Activated macrophage profile. PLoS One 7: e36814.
29. Epelman, S, Lavine, KJ, Beaudin, AE, Sojka, DK, Carrero, JA, Calderon, B et al. (2014). Embryonic and adult-derived resident cardiac macrophages are maintained through distinct mechanisms at steady state and during inflammation. Immunity 40: 91-104.
30. Narita, T, Shintani, Y, Ikebe, C, Kaneko, M, Harada, N, Tshuma, N et al. (2013). The use of cell-sheet technique eliminates arrhythmogenicity of skeletal myoblastbased therapy to the heart with enhanced therapeutic effects. Int J Cardiol 168: 261-269.
31. Hayashi, Y, Tsuji, S, Tsujii, M, Nishida, T, Ishii, S, Iijima, H et al. (2008). Topical transplantation of mesenchymal stem cells accelerates gastric ulcer healing in rats. Am J Physiol Gastrointest Liver Physiol 294: G778-G786.
32. Takagawa, J, Zhang, Y, Wong, ML, Sievers, RE, Kapasi, NK, Wang, Y et al. (2007). Myocardial infarct size measurement in the mouse chronic infarction model: comparison of area-And length-based approaches. J Appl Physiol (1985) 102: 2104-2111.
33. Rane, AA, Chuang, JS, Shah, A, Hu, DP, Dalton, ND, Gu, Y et al. (2011). Increased infarct wall thickness by a bio-inert material is insufficient to prevent negative left ventricular remodeling after myocardial infarction. PLoS One 6: e21571.